Dating site for aids patient
More likely, the worst case scenario is that it would simply not work as well.The case, at the Pitie-Salpetriere Hospital AP-HP in Paris, was detailed in a report in the Annals of Oncology journal, where the same doctors also gave a case study of another patient treated with Opdivo who did not show any HIV benefit.'We must remain careful, especially because this is only one case,' said Jean-Philippe Spano, a professor and head of the medical oncology department at the Paris hospital.These reservoirs of HIV-infected cells are found in the immune system in places like the brain, bone marrow and genital tract.They lie hidden and dormant, and can't be reached with standard anti-retroviral therapy HIV treatments.
A 51-year-old man with AIDS and lung cancer was given nivolumab - sold as Opdivo -which is used to treat lung, kidney or skin cancer.
However, every attempt to replicate his cure resulted in crippling outcomes and even death of the patient.
Scientists are still trying to understand why it worked for Brown, now healthy and living in California 10 years on, and why it didn't work for others.
Andrew Freedman, an infectious diseases expert at Britain's Cardiff University, said the case was 'potentially exciting'.
But like others, he advised caution.'It's difficult to speculate at this stage why the second patient did not show the same response,' he said in an emailed comment.